Genotypic diversity of complement component C4 does not predict kidney transplant outcome

Journal of the American Society of Nephrology

Volumn 22, Issue 2, 2011, Pages 367-376

  Wahrmann, Markus ^a   Döhler, Bernd ^b   Ruhenstroth, Andrea ^b   Haslacher, Helmuth ^a   Perkmann, Thomas ^a   Exner, Markus ^a   Rees, Andrew J ^a   Böhmig, Georg A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C4B; COMPLEMENT COMPONENT C4L; COMPLEMENT COMPONENT C4S; UNCLASSIFIED DRUG;

ADULT; ALLOGRAFT; ARTICLE; COHORT ANALYSIS; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DEATH; FEMALE; GENE DOSAGE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GRAFT RECIPIENT; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 79551654538     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010050513     Document Type: Article

References (39)

1. Sacks S, Lee Q, Wong W, Zhou W: The role of complement in regulating the alloresponse. Curr Opin Organ Transplant 14: 10-15, 2009
2. Murata K, Baldwin WM, 3rd: Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection. Transplant Rev 23: 139-150, 2009
3. Locke JE, Magro CM, Singer AL, Segev DL, Haas M, Hillel AT, King KE, Kraus E, Lees LM, Melancon JK, Stewart ZA, Warren DS, Zachary AA, Montgomery RA: The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection. Am J Transplant 9: 231-235, 2009
4. Tillou X, Poirier N, Le Bas-Bernardet S, Hervouet J, Minault D, Renaudin K, Vistoli F, Karam G, Daha M, Soulillou JP, Blancho G: Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboons. Kidney Int 78: 152-159, 2010
5. Pratt JR, Basheer SA, Sacks SH: Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 8: 582-587, 2002
6. Lin T, Zhou W, Farrar CA, Hargreaves RE, Sheerin NS, Sacks SH: Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. Am J Pathol 168: 1241-1248, 2006
7. Csencsits K, Burrell BE, Lu G, Eichwald EJ, Stahl GL, Bishop DK: The classical complement pathway in transplantation: Unanticipated protective effects of C1q and role in inductive antibody therapy. Am J Transplant 8: 1622-1630, 2008
8. Walport MJ: Complement: First of two parts. N Engl J Med 344: 1058-1066, 2001
9. Mauiyyedi S, Pelle PD, Saidman S, Collins AB, Pascual M, Tolkoff-Rubin NE, Williams WW, Cosimi AA, Schneeberger EE, Colvin RB: Chronic humoral rejection: Identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 12: 574-582, 2001
10. Böhmig GA, Exner M, Habicht A, Schillinger M, Lang U, Kletzmayr J, Säemann MD, Hörl WH, Watschinger B, Regele H: Capillary C4d deposition in kidney allografts: A specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 13: 1091-1099, 2002
11. Colvin RB: Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 18: 1046-1056, 2007 (Pubitemid 46536891)
12. Blanchong CA, Zhou B, Rupert KL, Chung EK, Jones KN, Sotos JF, Zipf WB, Rennebohm RM, Yung Yu C: Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in caucasians: The load of RCCX genetic diversity on major histocompatibility complex-associated disease. J Exp Med 191: 2183-2196, 2000
13. Yang Y, Chung EK, Zhou B, Blanchong CA, Yu CY, Fust G, Kovacs M, Vatay A, Szalai C, Karadi I, Varga L: Diversity in intrinsic strengths of the human complement system: Serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities, and body mass index. J Immunol 171: 2734-2745, 2003
14. Saxena K, Kitzmiller KJ, Wu YL, Zhou B, Esack N, Hiremath L, Chung EK, Yang Y, Yu CY: Great genotypic and phenotypic diversities associated with copy-number variations of complement C4 and RP-C4-CYP21-TNX (RCCX) modules: A comparison of Asian-Indian and European American populations. Mol Immunol 46: 1289-1303, 2009
15. Rowe PC, McLean RH, Wood RA, Leggiadro RJ, Winkelstein JA: Association of homozygous C4B deficiency with bacterial meningitis. J Infect Dis 160: 448-451, 1989
16. Bishof NA, Welch TR, Beischel LS: C4B deficiency: A risk factor for bacteremia with encapsulated organisms. J Infect Dis 162: 248-250, 1990
17. Yang Y, Chung EK, Wu YL, Savelli SL, Nagaraja HN, Zhou B, Hebert M, Jones KN, Shu Y, Kitzmiller K, Blanchong CA, McBride KL, Higgins GC, Rennebohm RM, Rice RR, Hackshaw KV, Roubey RA, Grossman JM, Tsao BP, Birmingham DJ, Rovin BH, Hebert LA, Yu CY: Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): Low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet 80: 1037-1054, 2007
18. Wu YL, Yang Y, Chung EK, Zhou B, Kitzmiller KJ, Savelli SL, Nagaraja HN, Birmingham DJ, Tsao BP, Rovin BH, Hebert LA, Yu CY: Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: Complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus. Cytogenet Genome Res 123: 131-141, 2008
19. Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC, French M, Mallal S, Christiansen F: The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 167: 257-274, 1999
20. Candore G, Modica MA, Lio D, Colonna-Romano G, Listi F, Grimaldi MP, Russo M, Triolo G, Accardo-Palumbo A, Cuccia MC, Caruso C: Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: A genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotype. Biomed Pharmacother 57: 274-277, 2003
21. Racusen LC, Halloran PF, Solez K: Banff 2003 meeting report: New diagnostic insights and standards. Am J Transplant 4: 1562-1566, 2004
22. Lee PC, Terasaki PI, Takemoto SK, Lee PH, Hung CJ, Chen YL, Tsai A, Lei HY: All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 74: 1192-1194, 2002 (Pubitemid 35216119)
23. Einecke G, Sis B, Reeve J, Mengel M, Campbell PM, Hidalgo LG, Kaplan B, Halloran PF: Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 9: 2520-2531, 2009
24. Gaston RS, Cecka JM, Kasiske BL, Fieberg AM, Leduc R, Cosio FC, Gourishankar S, Grande J, Halloran P, Hunsicker L, Mannon R, Rush D, Matas AJ: Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 90: 68-74, 2010
25. Seelen MA, Brooimans RA, van der Woude FJ, van Es LA, Daha MR: IFN-gamma mediates stimulation of complement C4 biosynthesis in human proximal tubular epithelial cells. Kidney Int 44: 50-57, 1993
26. Gerritsma JS, Gerritsen AF, De Ley M, van Es LA, Daha MR: Interferon-gamma induces biosynthesis of complement components C2, C4 and factor H by human proximal tubular epithelial cells. Cytokine 9: 276-283, 1997
27. Yang Y, Lhotta K, Chung EK, Eder P, Neumair F, Yu CY: Complete complement components C4A and C4B deficiencies in human kidney diseases and systemic lupus erythematosus. J Immunol 173: 2803-2814, 2004
28. Wu YL, Hauptmann G, Viguier M, Yu CY: Molecular basis of complete complement C4 deficiency in two North-African families with systemic lupus erythematosus. Genes Immun 10: 433-445, 2009
29. Mengel M, Bogers J, Bosmans JL, Seron D, Moreso F, Carrera M, Gwinner W, Schwarz A, De Broe M, Kreipe H, Haller H: Incidence of C4d stain in protocol biopsies from renal allografts: Results from a multicenter trial. Am J Transplant 5: 1050-1056, 2005
30. Haas M, Segev DL, Racusen LC, Bagnasco SM, Locke JE, Warren DS, Simpkins CE, Lepley D, King KE, Kraus ES, Montgomery RA: C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts. J Am Soc Nephrol 20: 197-204, 2009
31. Zhang X, Reed EF: Effect of antibodies on endothelium. Am J Transplant 9: 2459-2465, 2009
32. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF: Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 9: 2312-2323, 2009
33. Hirohashi T, Uehara S, Chase CM, Dellapelle P, Madsen JC, Russell PS, Colvin RB: Complement Independent Antibody-Mediated Endarteritis and Transplant Arteriopathy in Mice. Am J Transplant 10: 510-517, 2010
34. Falkeis C, Mark W, Sergi C, Heininger D, Neumair F, Scheiring J, Lhotta K: Kidney transplantation in patients suffering from hereditary complete complement C4 deficiency. Transpl Int 20: 1044-1049, 2007
35. Brown KM, Kondeatis E, Vaughan RW, Kon SP, Farmer CK, Taylor JD, He X, Johnston A, Horsfield C, Janssen BJ, Gros P, Zhou W, Sacks SH, Sheerin NS: Influence of donor C3 allotype on late renal-transplantation outcome. N Engl J Med 354: 2014-2023, 2006
36. Varagunam M, Yaqoob MM, Dohler B, Opelz G: C3 polymorphisms and allograft outcome in renal transplantation. N Engl J Med 360: 874-880, 2009
37. Szilagyi A, Fust G: Diseases associated with the low copy number of the C4B gene encoding C4, the fourth component of complement. Cytogenet Genome Res 123: 118-130, 2008
38. Szilagyi A, Blasko B, Szilassy D, Fust G, Sasvari-Szekely M, Ronai Z: Real-time PCR quantification of human complement C4A and C4B genes. BMC Genet 7: 1, 2006
39. Wu YL, Savelli SL, Yang Y, Zhou B, Rovin BH, Birmingham DJ, Nagaraja HN, Hebert LA, Yu CY: Sensitive and specific real-time polymerase chain reaction assays to accurately determine copy number variations (CNVs) of human complement C4A, C4B, C4-long, C4-short, and RCCX modules: Elucidation of C4 CNVs in 50 consanguineous subjects with defined HLA genotypes. J Immunol 179: 3012-3025, 2007